RR
Rakesh Raghuwanshi
About Rakesh Raghuwanshi
Data last updated:
Rakesh Raghuwanshi is a Director at Neomatis Pharma Private Limited (since 2024) and Director at Clanjewel Lifescience Private Limited (since 2025). The companies operate in Chemicals. The largest current company by reported revenue is Neomatis Pharma Private Limited at ₹98.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jan 2024 | 2021 | ₹98.9 Lakh (FY 2025) | Active | |
| Director | 20 Aug 2025 | 2025 | Active |
Board colleagues of Rakesh Raghuwanshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramakant Yaduvanshi | 07972154 | Neomatis Pharma Private Limited | Director |
| Sanjeev Purviya | 09236612 | Neomatis Pharma Private Limited | Director |
| Neha Raghuwanshi | 11251430 | Clanjewel Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Raghuwanshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Raghuwanshi
Rakesh Raghuwanshi currently holds 2 directorships: Neomatis Pharma Private Limited (Director, since 03 Jan 2024, revenue ₹98.9 Lakh (FY 2025)); Clanjewel Lifescience Private Limited (Director, since 20 Aug 2025).
Rakesh Raghuwanshi was first appointed on 03 Jan 2024 as Director at Neomatis Pharma Private Limited. The most recent appointment on record is 20 Aug 2025 at Clanjewel Lifescience Private Limited.
The current boards of Rakesh Raghuwanshi's companies include Ramakant Yaduvanshi (Neomatis Pharma Private Limited), Sanjeev Purviya (Neomatis Pharma Private Limited), Neha Raghuwanshi (Clanjewel Lifescience Private Limited).